Stoxx Europe 50
|
4 596,94
|
2,61
|
0,06 %
|
Analysen zu Stoxx Europe 50-Werten
| 30.07.25 | Intesa Sanpaolo Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | UBS Outperform | RBC Capital Markets | |
| 30.07.25 | Santander Buy | UBS AG | |
| 30.07.25 | Santander Sector Perform | RBC Capital Markets | |
| 30.07.25 | Hermès Outperform | RBC Capital Markets | |
| 30.07.25 | Rio Tinto Hold | Jefferies & Company Inc. | |
| 30.07.25 | Hermès Buy | UBS AG | |
| 30.07.25 | EssilorLuxottica Market-Perform | Bernstein Research | |
| 30.07.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 30.07.25 | Santander Neutral | JP Morgan Chase & Co. | |
| 30.07.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.07.25 | HSBC Holdings Buy | Jefferies & Company Inc. | |
| 30.07.25 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 30.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | L'Oréal Underweight | JP Morgan Chase & Co. | |
| 30.07.25 | Air Liquide Outperform | Bernstein Research | |
| 30.07.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 29.07.25 | L'Oréal Hold | Jefferies & Company Inc. | |
| 29.07.25 | Novo Nordisk Halten | DZ BANK | |
| 29.07.25 | EssilorLuxottica Kaufen | DZ BANK | |
| 29.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.07.25 | AstraZeneca Outperform | Bernstein Research | |
| 29.07.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.07.25 | EssilorLuxottica Market-Perform | Bernstein Research | |
| 29.07.25 | Air Liquide Outperform | Bernstein Research | |
| 29.07.25 | Shell Outperform | RBC Capital Markets | |
| 29.07.25 | AstraZeneca Buy | UBS AG | |
| 29.07.25 | Air Liquide Buy | Jefferies & Company Inc. | |
| 29.07.25 | Air Liquide Buy | UBS AG | |
| 29.07.25 | BNP Paribas Kaufen | DZ BANK | |
| 29.07.25 | Air Liquide Neutral | JP Morgan Chase & Co. | |
| 29.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.07.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 29.07.25 | SAP Buy | Goldman Sachs Group Inc. | |
| 29.07.25 | EssilorLuxottica Neutral | UBS AG | |
| 29.07.25 | SAFRAN Outperform | RBC Capital Markets | |
| 29.07.25 | EssilorLuxottica Overweight | JP Morgan Chase & Co. | |
| 28.07.25 | SAP Buy | Jefferies & Company Inc. |
HOT STOCKS DER LETZTEN 3 TAGE
| Novo Nordisk | 4 |
| Roche | 2 |
| EssilorLuxottica | 2 |
| AB InBev | 2 |
| Unilever | 1 |
| Richemont | 1 |
| VINCI | 1 |
| BNP Paribas | 1 |
| Deutsche Telekom | 1 |
| SAP | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.